Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Friedman

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The American Review of Respiratory Disease|April 1, 1993
Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responsesB S Friedman, E H Bel, A Buntinx, et al.
British Journal of Clinical Pharmacology|July 1, 1995
Pharmacokinetic and pharmacodynamic analysis of a novel leukotriene biosynthesis inhibitor, MK-0591, in healthy volunteersT Uematsu, M Kanamaru, K Kosuge, et al.
Clinical Pharmacology and Therapeutics|March 1, 1995
Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitisJ Hillingsø, J Kjeldsen, L S Laursen, et al.
The Journal of Allergy and Clinical Immunology|January 1, 1995
The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivoZ Diamant, M C Timmers, H van der Veen, et al.
Health Services Research|April 1, 1990
The whole is greater than the sum of its parts: the anatomy of the Department of Veterans Affairs Medical District 17 Health Services Research and Development Field ProgramJ G Demakis, R S Turpin, K J Conrad, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The American Review of Respiratory Disease|April 1, 1993
Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responsesB S Friedman, E H Bel, A Buntinx, et al.
British Journal of Clinical Pharmacology|July 1, 1995
Pharmacokinetic and pharmacodynamic analysis of a novel leukotriene biosynthesis inhibitor, MK-0591, in healthy volunteersT Uematsu, M Kanamaru, K Kosuge, et al.
Clinical Pharmacology and Therapeutics|March 1, 1995
Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitisJ Hillingsø, J Kjeldsen, L S Laursen, et al.
The Journal of Allergy and Clinical Immunology|January 1, 1995
The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivoZ Diamant, M C Timmers, H van der Veen, et al.
Health Services Research|April 1, 1990
The whole is greater than the sum of its parts: the anatomy of the Department of Veterans Affairs Medical District 17 Health Services Research and Development Field ProgramJ G Demakis, R S Turpin, K J Conrad, et al.
Pageof 2